跳至主要内容
临床试验/IRCT138803241696N2
IRCT138803241696N2已完成2 期

Clinical trial phase II of oral hebal compoenent (BMP) in patient with multiple sclerosis

Iran Rheumatism Center0 个研究点目标入组 10 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
10

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 65 years(—)
性别
All

入选标准

  • Age between 18 and 50
  • Multiple sclerosis diagnosis by Mac Donald criteria
  • EDSS more than six
  • Signing informed consent
  • Exclusion criteria:
  • Sever hepatic/ Renal or cardiac diease
  • Sever psychological disorders
  • Adminstration of IVIG, Mitoxantrone, Plasmapheresis or immunosupressive drug since three months before
  • Pegnancy or intention to pregnancy

排除标准

  • 未提供

研究者

发起方
Iran Rheumatism Center

相似试验

已完成
3 期
An open label clinical trial of an orally-dosed herbal formulation Zinova (Registered Trademark) for the prevention of dysmenorrhoea (menstrual pain).DysmenorrhoeaAlternative and Complementary Medicine - Herbal remediesReproductive Health and Childbirth - Menstruation and menopause
ACTRN12612000149864Applied Science and Nutrition Pty. Ltd.20
已完成
1 期
Phase-I Clinical Trial to study the Safety of oral drug Bioplatin in patients of Advanced metastatic Solid Tumours and those who are resistant to conventional treatments
CTRI/2017/06/008778Rasayani Biologics Pvt Ltd14
已完成
不适用
Phase II clinical trial of the combination of high-dose toremifene and exemestane for advanced/recurrent breast cancer unresponsive to nonsteroidal aromatase inhibitorsAdvanced/recurrent breast cancer
JPRN-UMIN000004345Kyoto Prefectural University of Medicine30
已完成
1 期
Phase I/II trial of oral hydroxyurea in combination with pegylated interferon and ribavirin in chronic hepatitis C patientsChronic hepatitis C
JPRN-UMIN000003457Yokohama City University Medical Center Gastroenterological Center20
进行中(未招募)
1 期
Phase II clinical trial on the combination of avelumab and axitinib for the treatment of patients with recurrent glioblastomarecurrent glioblastomaMedDRA version: 19.1Level: PTClassification code 10018337Term: Glioblastoma multiformeSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 19.1Level: PTClassification code 10018336Term: GlioblastomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)
EUCTR2017-000200-23-BEZ Brussel54